Manuscript accepted on :29-Dec-2020
Published online on: 04-01-2021
Plagiarism Check: Yes
Reviewed by: Dr. Flavio Palmieri
Second Review by: Dr. Ankur Singh Bist
Final Approval by: Dr. Ayush Dogra
Views:
PDF Downloads:
Nazim Hussain1*, BibhutiBhushan Kakoti1, Mithun Rudrapal1, Zubaidur Rahman2, Mokinur Rahman2, Devid Chutia3and Khomendra Kumar Sarwa4
1Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India.
2Department of Pharmaceutical Sciences, North East Frontier Technical University, Along, Arunachal Pradesh, India.
3Department of Pharmacology, Himalayan Pharmacy Institute, Majhitar, Sikkim, India.
4Department of Pharmacy, Govt. Girls Polytechnic, Raipur, Chhattisgarh, India.
Corresponding Author E-mail: nhussain116@gmail.com
DOI : https://dx.doi.org/10.13005/bpj/2090
Abstract
Cordia dichotoma Forst.has been used in the management of pain and inflammations in traditional medicine. However, the anti-inflammatory activity of the methanolic extract of C. dichotoma(MECD) bark has not been reported so far. This work was, therefore, aimed at investigating the anti-inflammatory activity of C. dichotomabark extract. The antioxidant activity was evaluated to justify the anti-inflammatory action of MECD on the basis of its radical scavenging property. The extract of C. dichotomawas obtained by Soxhlation of bark powder using methanol as solvent. The anti-inflammatory activity was determined by the carrageenan induced paw edemamodel in ratsat two different dose levels, viz., 250 and 500 mg/kg. The antioxidant activity was evaluated using DPPH radical scavenging assay. The antioxidant activity was performed in vitro by DPPH radical scavenging assay using ascorbic acid as the standard drug. In anti-inflammatory activity, maximum inhibition of edema was observed after 4 hours of experimental period. At lower test dose (250 mg/kg b.w.), the percentage inhibition of paw edema was 29.7 %, while 48.6 % inhibition of edema was observed at higher dose (500 mg/kgb.w.). The percentage inhibition of paw edema was significant relative to the control group. The standard indomethacin group also exhibited sufficiently high level of anti-inflammatory effect with 56% inhibition of paw edema at 5 mg/kg dose. In in vitroantioxidant activity, the MECD exhibited good DPPHradical scavenging activity with the IC50 vale of 62.46 µg/ml, whereas the standard drug, ascorbic acid showed comparatively more antioxidant activity with IC50 of 27.66 µg/ml.However, our study scientifically validates the folkloric claim as well as traditional uses of C. dichotomaas anti-inflammatory medication. It is suggested that the anti-inflammatory activity of C. dichotomamay be due to the antioxidant potential of phenolic phytoconstituents or plant flavonoids present in the methanolic bark extract.
Keywords
Anti-Inflammatory Activity; Antioxidant Property; Cordia Dichotoma; Flavonoids; Methanolic Extract
Download this article as:
| Copy the following to cite this article: Hussain N, Kakoti B. B, Rudrapal M, Rahman Z, Rahman M, Chutia D, Sarwa K. K. Biomed Pharmacol J 2020;13(4). |
| Copy the following to cite this URL: Hussain N, Kakoti B. B, Rudrapal M, Rahman Z, Rahman M, Chutia D, Sarwa K. K. Biomed Pharmacol J 2020;13(4). Available from: https://bit.ly/3rTuIwP |
Introduction
Chronic inflammatory diseases remain to be one of the major medical problems around the world. According to the World Health Organization (WHO), chronic inflammatory diseases are considered as the significant threat to public health. The prevalence of chronic inflammatory disorders is increasing with 17.6 million clinical cases, particularly due to rheumatoid arthritis every year globally [1]. Approximately 3 of 5 people die and 50% of all deaths occur have been attributable to chronic inflammation-related diseases such as cardiovascular diseases (stroke, heart disorders), chronic respiratory diseases (allergic asthma, COPD), rheumatoid arthritis and joint disorders, systemic lupus erythematosus, inflammatory bowel disease (IBD), Crohn’s disease, Alzheimer’s disease, cancer, obesity, diabetes, chronic kidney disease and many others [2]. Some common FDA approved medications that include Non-steroidal anti-inflammatory drugs (NSAIDs), steroidal drugs and immuno suppressants are commonly used for the treatment of inflammatory disorders. These drug therapies are required to be administered for a long time and their use often induce some serious adverse effects such as gastrointestinal upset, heart burn, peptic ulcers, headache and so on.Because of this reason, there is an increasing need to develop some new and alternative anti-inflammatory drugs that would not only be efficacious against inflammatory illness and diseases, but also be safe and produce fewer side effects.
Plant-based traditional remedies have been used for the treatment of human diseases for thousands of years. About 80% of population depends on traditional herbal remedies for primary health care across the globe [3]. Traditional or folklore herbal medicines play a significant role in the management of a variety of human disorders including cancer, neurological disorders, diabetes and pain and inflammatory disorders, just to name a few [4]. WHO has recommended the evaluation of traditional plant-based remedies or herbal preparations for antidiabetic activity because they are more effective and safe as compared to synthetic antidiabetic drugs [5]. In addition, herbal medicines have the property of synergistic action due to the presence of a variety of active constituents in a single drug/ medicinal preparation. Numerous indigenous medicinal plants of India have been found to be useful in the management of pain and inflammations. Ayurveda, Unani and Siddha, are the notable systems of medication documented in ancient practice basically utilizing plants/ plant-based preparations as medicines for curing human ailments/ diseases like diabetes [6]. In view of their traditional and ethnopharmacological importance, herbal medicine may have potential role in the management of pain and inflammations. Moreover, medicinal plants provide valuable source of new chemical moieties with potential therapeutic properties. Plants that have been found to have anti-inflammatory potential can be screened in search for novel bioactive secondary metabolites or phytoconstituents as new and effective, but safe anti-inflammatory agents.
Oxidative stress (OS) induced by the reactive oxygen species (ROS) produced from the action of free radicals in the biological matrix may be increased abnormally during diabetes, causing an imbalance between the cellular metabolism and the antioxidant system of the body. The oxidative stress produces several inflammatory cascades that damage the cellular components [7].Further, oxidative stress is undoubtedly claimed to have significant role in the progression of chronic inflammation mediated diseases. The cellular oxidative stress can besuppressed to an appreciable extent by potentiating the action of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GSH) and glutathione peroxidase (GPx) by alternative herbal therapies [8].
Cordia dichotomaForst. (also known as Indian cherry) belonging to the family Boraginaceae is an average-sized tree of tropical and subtropical origin. It is widely found in Sri Lanka, India, and other tropical regions of the world. The use of this plant has been on ancient practice for the management of a variety of human disorders. It is also an important plant species found in various traditional Indian systems of medicine including Ayurveda, Unani and Siddha [9]. Seeds of C. dichotoma are used for the management of various inflammatory disorders [10]. Fruits are used as expectorant, astringent, laxative and anthelmintic[9]. Some common ethnomedinal uses of C. dichotomaincludes antidiabetic, immuno modulator, diuretic, anthelmintic, wound healing, antiulcer, gastro-protective, anti-inflammatory, antileprotic, antidiabetic, and hepatoprotective and antioxidant activities [10]. The bark of C. dichotomahas been reported to a variety of phytoconstituents such as betulin, α-amyrin, octacosanol, β-sitosterol, lupeol-3-rhamnoside, β-sitosterol-3-glucoside, hentricontanol, taxifolin-3,5-dirhmnoside, and hesperitin-7-rhamnoside [9, 11].
There has been no scientific study on the the anti-inflammatory activity of the C. dichotoma bark previously reported in literature. The present study was, therefore, aimed at investigating the anti-inflammatory activity of the methanolic extract of C. dichotoma bark (MECD) with a view to justify the traditional use of this particular plant species in the treatment of edema.The antioxidant activity was evaluated to justify the anti-inflammatory action of MECD on the basis of its radical scavenging effect.
Materials and Methods
Drugs and chemicals
Carrageenan and indomethacin were purchased from Merck Pvt. Ltd., Mumbai, India. Carboxy methyl cellulose (CMC) was procured from Sigma-Aldrich, Mumbai, India. All other chemicals and solvents used in this study were of analytical grade.
Plant material
The barks of C. dichotomaForst.were collected during the month of April-May, 2012 from the Duhai forest of Ghaziabad, Uttar Pradesh, India. The plant material was identified from CSIR-National Institute of Science Communication and Information Resources (CSIR-NISCAIR), New Delhi. A voucher specimen (NISCAIR/RHMD/ Consult/2012-13/2025/33) of the bark of C. dichotoma was submitted at the herbarium for future reference.
Extraction methodology
The shade-dried barks of C. dichotoma were pulverized to coarse powder, defatted using petroleum ether, and extracted by Soxhlation using methanol as solvent. The methanolic extract was subsequently evaporated to dryness and the concentrated extract so obtained was preserved in a refrigerator at 4 oC for further use. The percentage yield of the methanolic bark extract of C. dichotoma (MECD) was found to be 7.11% w/w on dry weight basis.
Phytochemical analysis
The MECD was analysedfor the presence of presence of phytoconstituents as per the standard procedure previously described in literature [12].
Experimental animals
Adult Wistarfemale albino rats weighing around 300-330 g were procured from the Institutional Animal House for the experimental study. Acclimatizationof animals was done in accordance with standard laboratory conditions (temperature: 25 ± 2 oC, relative humidity: 50 ± 5 %) with a 12 h light/12 h dark cyclefor a week prior to the beginning of experiments, and were provided with free access to the standard pellet diet and drinking water ad libitum. The experimental protocol was approved by the IAEC vide approval no. IAEC/DU/58 dated. 24/09/2013.
Acute toxicity study
The oral acute toxicity of MECD was done as per OECD guidelines. The rats were randomly distributed into seven groups of three animals each. The first three groups were administered with MECD at 10, 100, and 1000 mg/kg doses, respectively. The animals were observed for signs of mortality or morbidity or death for 24 hours. Further, doses of 2,000, 3,000, and 5,000 mg/kg were given to rest of the three groups and observed for 48 hours. One group administered with vehicle was treated as normal control [4].
Evaluation of anti-Inflammatory activity
The anti-inflammatory activity was evaluated by carrageenan induced rat paw edema method according to the previously reported methods [13-16] with minor modifications.The rats were randomly distributed into five groups containing six rats in each group (one control, one toxic, standard and two test groups). The acute inflammation in rats was induced by the injecting carrageenan (1% w/v solution in 0.9 % w/v sodium chloride, 0.1 ml) in the planter region of rat’s paw. The extract wasformulated in two different doses (250 and 500 mg/kg body weight) in the form of a suspension using 0.3% CMC.The extract formulations were administered orally into experimental animals one hour prior to injecting carrageenan. Indomethacin (5 mg/kg body weight, oral route) was used as standard drugs.
Group 1 (Control): 0.3 % CMC (10 ml/kg body weight), orally
Group 2 (Toxic): 1 % Carrageenan (0.1 ml)
Group 3 (Standard): Indomethacin (2 ml, 5 mg/kg body weight), orally + 1 % Carrageenan (0.1 ml), orally
Group 4 (Low dose test): MECD (250 mg/kg body weight), orally + 1 % Carrageenan (0.1 ml), by injection
Group 5 (High dose test): MECD (500 mg/kg body weight), orally + 1 % Carrageenan (0.1 ml), by injection
The paw volume was measured using a Plethysmometerat 0, 1, 3 and 4 hours after the administration of carrageenan. The percentage inhibition of paw edema was estimated using the following formula.
% Inhibition of edema = (Vt-Vc/Vt) × 100
where, Vt = Paw volume in test group, Vc = Paw volume in control group
Antioxidant activity
The in vitro antioxidant activity was evaluated by 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical scavenging assay method [5, 8]. A solution of 0.1 mM DPPH in methanol was prepared and 2.4 ml of this solution was mixed with 1.6 ml of the MEXD in methanol at different test concentrations (10-200 μg/ml). The reaction mixture was vortexed thoroughly and kept at room temperaturein the dark for 30 min. The absorbance of the mixture was determined spectrophotometrically at 517 nm. Ascorbic acid was used as standard drug. The experiment was carried out in triplicate observations.The percentage of radical scavenging activity was calculated using the following formula.Then % of inhibition of scavenging activity was plotted against concentration and from the graph IC50 was calculated.
Percentage inhibition = (Ao-At/Ao) × 100
where, Ao and At are absorbance values of the control and the test compound (standard/ test), respectively
Statistical Analysis
Results are presented as mean ± standard error of mean (SEM). The one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test was used to analyse data. Statistical analysis was performed using the IBM SPSS 19.0 statistical software package, for Windows. Statistical differences at 1% (p < 0.01) level of probability between the groups were considered statistically significant.
Results and Discussion
Phytochemical analysis
Qualitative phyto chemical analysis showed the presence of alkaloids, steroids, cardiac glycosides, flavonoids, tannins, terpenoids, saponins and carbohydrate in the MECD.
Acute oral toxicity
Results of oral acute toxicity study revealsthat the LD50 of the MECD was above 5,000 mg/kg body weight. No gross behavioural changes, other symptoms of toxicity and mortality were observedup to 48 hours of experimentation. The body weight and food consumption of treated rats were normal as compared to vehicle control.
Anti-inflammatory activity
The MECDshowed anti-inflammatory activity against carrageenan-induced paw edema model in rats. The extract exhibited dose-dependent anti-inflammatory activity. Maximum inhibition of edema was observed after 4 hours of experimental period. At lower test dose (250 mg/kg b.w.), the percentage inhibition of paw edema was 29.7 %, while 48.6 % inhibition of edema was observed at higher dose (500 mg/kgb.w.). Results of anti-inflammatory activity are presented in Figure 1. Both lower and higher test doses of the MECD demonstrated significant (p< 0.01) inhibition of paw edema as compared to control group. The standard indomethacin group also exhibited sufficiently high level of anti-inflammatory effect with 56% inhibition of paw edema at 5 mg/kg dose, relative to the control group. The anti-inflammatory effect of MECD is comparable to some extent with that of the standard drug, indomethacin.
 |
Figure 1: Effect of MECD on carrageenan-induced paw edema Values are expressed as mean ± SEM (n=6); statistically significant at **p < 0.01, compared to normal control. |
Antioxidant activity
In the in vitro radical scavenging activity, the significant reduction in the DPPH radicals was seen due to the free radical scavenging property of MCED. The antioxidant activityrose with increasing the concentration of the test extract, reachingmaximum level with the IC50vale of 62.46 µg/ml. On the other hand, the standard drug, ascorbic acid exhibited comparatively more antioxidant activity with IC50of 27.66 µg/ml (Figure 2). However, the MECD extract of C. dichotoma bark possesses antioxidant activity.
 |
Figure 2: DPPH radical scavenging activity Values are expressed as mean ± SEM (n=3). |
Results reveal the anti-inflammatory potential of the MECD of C. dichotoma bark along with antioxidant property. It is attributed that the anti-inflammatory effect might be due to the phytochemical content such as phenolic compounds, flavonoids, saponins or alkaloids of the extract. Many studies have investigated the antioxidant potential of plant polyphenols and flavonoids. Phenolic phytoconstituents and flavonoids have been attributed to exhibit pharmacological effects against heart diseases, cancer, neurological disorders, diabetes, inflammatory disorders and so on owing to their radical scavenging actions [17-19]. Literature reports suggest that the flavonoids content of plant extract may be responsible for the anti-inflammatory effect which might be because of their radical scavenging actions [20]. The antioxidant activity of MECD can help reduce the oxidative stress induced generation of inflammatory mediators and associated tissue damages. Restoring the levels of antioxidant enzymes, herbal drugs could act as free-radical scavengers and eventually prevent generation of ROS and thereby OS induced cellular damages [21, 22].In this study, the antioxidant activity of MECD may be the underlying reason behind its anti-inflammatory action. Phenolic compounds and flavonoids of MECD could reduce cellular oxidative stress induced inflammatory damages.
Conclusion
It is concluded that the methanolic extract of C. dichotoma(MECD) bark possesses anti-inflammatory activity in carrageenan-induced paw edemamodel in rats. Our study scientifically validates the folkloric claim as well as traditional uses of C. dichotomaas anti-inflammatory medication. It is suggested that the anti-inflammatory activity of C. dichotomamay be due to the presence of phenolic phytoconstituents or plant flavonoids in the methanolic bark extract. Further studies can be carried out in order to identify the specific phytochemical(s) responsible for the anti-inflammatory potential of C. dichotoma..
Conflict of Interest
The authors declare that there are no conflicts of interest.
References
- Understanding and Managing Chronic Inflammation. Available from URL: https://www.healthline.com/health/chronic-inflammation (accessed on 30/07/2020)
CrossRef - Furman D, Campisi1 J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019; 25: 1822-1832
CrossRef - Junejo JA, Rudrapal M, Nainwal LM, Zaman K. Antidiabetic activity of hydro-alcoholic stem bark extract of Callicarpaarborea with antioxidant potential in diabetic rats. Biomed Pharmacother 2017; 95: 84-94
CrossRef - Junejo JA, Zaman K, Rudrapal M, Mondal M, Singh KD, Verma VK. Preliminary phytochemical and physicochemical evaluation of Caralliabrachiata(Lour.)Merr.Leaves.J App Pharm Sci2014; 4(12): 123-127
CrossRef - Junejo JA, Gogoi G, Islam J, Rudrapal M, Mondal P, Hazarika H, et al. Exploration of antioxidant, antidiabetic and hepatoprotective activity of Diplaziumesculentum, a wild edible plant from North Eastern region of India. Future J Pharm Sci 2018; 4: 93-101
CrossRef - Junejo JA, Mondal P, Rudrapal M, ZamanK. Antidiabetic assessment of the hydro-alcoholic leaf extracts of the plant Tetrastigmaangustifolia(Roxb.), a traditionally used North-Eastern Indian vegetable. Biomed Pharmacol J 2014; 7(2): 635-644
CrossRef - Junejo JA, Rudrapal M, Zaman K. Antidiabetic activity of Caralliabrachiata leaves hydro-alcoholic extract (HAE) with antioxidant potential in diabetic rats. Indian J Nat Prod Resour 2020; 11(1): 18-29
- Junejo JA, Zaman K, Rudrapal M, Hussain N. Antidiabetic and Antioxidant Activity of Hydro-alcoholic Extract of Oxalis debilisKunth Leaves in Experimental Rats. Biosci Biotech Res Comm 2020; 13(2):860-867
CrossRef - Hussain N, Kakoti BB, Rudrapal M, Laskar MA. A Concise Review on Cordia dichotoma J Global Trends Pharm Sci 2020; 11(4): 8744-8747
- Kuppast IJ, Nayak PV. Wound healing activity of Cordia dichotoma fruits. Nat Prod Rad 2006; 5: 103-107
- Jamkhande PG, Barde SR, Patwekar SL, Tidke PS. Plant profile, phytochemistry and pharmacology of Cordia dichotoma (Indian cherry): A review. Asian Paci Journal of Trop Biomed 2013; 3(12): 1009-1012
CrossRef - Junejo JA, Zaman K, Rudrapal M, Khan A, Sarwa KK, Suryawanshi VK, et al. Antidiarrheal and Antipyretic Activity of Ethyl Acetate and Hydro-Alcoholic Extracts of DiplaziumEsculentumLeaves. Biosci Biotech Res Comm 2020; 13(1): 169-173
CrossRef - Okunrobo L, Sifoh C, Ching P, Bariweni M. Anti-inflammatory evaluation of methanol extract and aqueous fraction of the leaves of Anthocleistadjalonensis Chev (Gentianaceae). Internet J Pharmacol 2009; 7(1).
CrossRef - Singh M, Kumar V, Singh I, Gauttam V, Kalia AN. Anti-inflammatory activity of aqueous extract of Mirabilis jalapa leaves. Pharmacogn Res 2010; 2(6): 364-367
CrossRef - Sarwa KK, Mazumder B, Rudrapal M. Topical ethosomalcapsaicinoids attenuates edema and nociception in arthritic rats. Drug Deliv 2015; 22(8): 1043-1052
CrossRef - Sarwa KK, Mazumder B, Rudrapal M, Verma VK. Potential of capsaicin loaded transferosomes in arthritic rats. Drug Deliv 2015; 22(5): 638-646
CrossRef - Laura FM, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin‐1β generation. ClinExpImmunol2007; 147(2): 227-235
- Gambhire MS, Wankhede AJ, Juvekar AR. Anti-inflammatory activity of aqueous extract of Barleriacristata J Young Pharm 2009; 1(3): 220-224
CrossRef - Ahmadiani A, Fereidoni M, Semnanian S, Kamalinejad M, Saremi S. Antinociceptive and anti-inflammatory effects of Sambucusebulus rhizome extract in rats. J Ethnopharmacol1998; 61(3): 229-235
CrossRef - Paliwal SK, Sati B, Faujdar S, Sharma S. Studies on analgesic, anti-inflammatory activities of stem and roots of InulacuspidataB Clarke. J Tradit Complement Med 2017; 7(4): 532-537
CrossRef - Naher S, Aziz MA, Akter MI, Rahman SMM, Sajon SR. Analgesic, anti-inflammatory and anti-pyretic activities of methanolic extract of Cordylinefruticosa (L.) A. Chev. leaves. J Res Pharm 2019; 23 (2): 198-207
CrossRef - Amri O, Zekhnini A, Bouhaimi A, Tahrouch S, Hatimi A.Anti-inflammatory Activity of Methanolic Extract from Pistaciaatlantica Leaves.Pharmacogn J 2018; 10(1): 71-76
CrossRef
